QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: BIOLOGICAL: avelumab|BIOLOGICAL: bevacizumab|DRUG: capecitabine|DRUG: cisplatin|DRUG: cyclophosphamide|DRUG: 5-Fluorouracil|DRUG: Leucovorin|DRUG: nab-paclitaxel|DRUG: Lovaza|RADIATION: Stereotactic Body Radiation Therapy|BIOLOGICAL: ALT-803|BIOLOGICAL: ETBX-011|BIOLOGICAL: ETBX-051|BIOLOGICAL: ETBX-061|BIOLOGICAL: GI-4000|BIOLOGICAL: GI-6207|BIOLOGICAL: GI-6301|BIOLOGICAL: haNK
Sponsor: ImmunityBio, Inc.